These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9126321)

  • 41. Transcriptional regulation of topoisomerase II alpha at confluence and pharmacological modulation of expression by bis-benzimidazole drugs.
    Tolner B; Hartley JA; Hochhauser D
    Mol Pharmacol; 2001 Apr; 59(4):699-706. PubMed ID: 11259613
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design of a hairpin polyamide, ZT65B, for targeting the inverted CCAAT box (ICB) site in the multidrug resistant (MDR1) gene.
    Buchmueller KL; Taherbhai Z; Howard CM; Bailey SL; Nguyen B; O'Hare C; Hochhauser D; Hartley JA; Wilson WD; Lee M
    Chembiochem; 2005 Dec; 6(12):2305-11. PubMed ID: 16254941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CBF/NF-Y functions both in nucleosomal disruption and transcription activation of the chromatin-assembled topoisomerase IIalpha promoter. Transcription activation by CBF/NF-Y in chromatin is dependent on the promoter structure.
    Coustry F; Hu Q; de Crombrugghe B; Maity SN
    J Biol Chem; 2001 Nov; 276(44):40621-30. PubMed ID: 11514576
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NF-M trans-activates the human DNA topoisomerase II alpha promoter independently of c-Myb in HL-60 cells.
    Brandt TL; Kroll DJ
    Leuk Res; 1997 Aug; 21(8):711-20. PubMed ID: 9379678
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isolation and characterization of the promoter region of the rat DNA topoisomerase II alpha gene.
    Park SH; Yoon JH; Cho HA; Kwon YD; Seong RH; Hong SH; Park SD
    J Biochem; 1995 Oct; 118(4):725-33. PubMed ID: 8576085
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence for repressional role of an inverted CCAAT box in cell cycle-dependent transcription of the human DNA topoisomerase IIalpha gene.
    Falck J; Jensen PB; Sehested M
    J Biol Chem; 1999 Jun; 274(26):18753-8. PubMed ID: 10373491
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of an inverted CCAAT element in transcriptional activation of the human DNA topoisomerase IIalpha gene by heat shock.
    Furukawa M; Uchiumi T; Nomoto M; Takano H; Morimoto RI; Naito S; Kuwano M; Kohno K
    J Biol Chem; 1998 Apr; 273(17):10550-5. PubMed ID: 9553115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 1,10-Phenanthroline-copper ion nuclease footprinting of DNA-protein complexes in situ following mobility-shift electrophoresis assays.
    Papavassiliou AG
    Methods Mol Biol; 1994; 30():43-78. PubMed ID: 8004214
    [No Abstract]   [Full Text] [Related]  

  • 49. Electrophoretic mobility-shift assays.
    Carey MF; Peterson CL; Smale ST
    Cold Spring Harb Protoc; 2013 Jul; 2013(7):636-9. PubMed ID: 23818676
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overexpression of ICBP90, a novel CCAAT-binding protein, overcomes cell contact inhibition by forcing topoisomerase II alpha expression.
    Hopfner R; Mousli M; Oudet P; Bronner C
    Anticancer Res; 2002; 22(6A):3165-70. PubMed ID: 12530060
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A 96-well DNase I footprinting screen for drug-DNA interactions.
    Ellis T; Evans DA; Martin CR; Hartley JA
    Nucleic Acids Res; 2007; 35(12):e89. PubMed ID: 17586817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Binding of f-PIP, a pyrrole- and imidazole-containing triamide, to the inverted CCAAT box-2 of the topoisomerase IIalpha promoter and modulation of gene expression in cells.
    Le NM; Sielaff AM; Cooper AJ; Mackay H; Brown T; Kotecha M; O'Hare C; Hochhauser D; Lee M; Hartley JA
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6161-4. PubMed ID: 17011187
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of topoisomerase-DNA interactions by electrophoretic mobility shift assay.
    Shuman S
    Methods Mol Biol; 2001; 95():65-74. PubMed ID: 11089220
    [No Abstract]   [Full Text] [Related]  

  • 54. Novel localizations and interactions of intercellular bridge proteins revealed by proteomic profiling†.
    Iwamori T; Iwamori N; Matsumoto M; Imai H; Ono E
    Biol Reprod; 2020 Apr; 102(5):1134-1144. PubMed ID: 31995159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Topoisomerase II hypersensitive sites in the 5'-terminal region of human dystrophin gene.
    Bystritskii AA; Hancock R; Razin SV; Yarovaya OV
    Dokl Biochem Biophys; 2001; 378():198-200. PubMed ID: 11712179
    [No Abstract]   [Full Text] [Related]  

  • 56. [Structure and function of type II DNA topoisomerases from higher eukaryotes].
    Adachi N
    Seikagaku; 1995 Jan; 67(1):36-40. PubMed ID: 7706846
    [No Abstract]   [Full Text] [Related]  

  • 57. ICBS ABSTRACTS.
    Transfusion; 2016 Jun; 56(6):1A-12A. PubMed ID: 27264015
    [No Abstract]   [Full Text] [Related]  

  • 58. The regulation of DNA supercoiling across evolution.
    Duprey A; Groisman EA
    Protein Sci; 2021 Oct; 30(10):2042-2056. PubMed ID: 34398513
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIalpha.
    Stros M; Polanská E; Struncová S; Pospísilová S
    Nucleic Acids Res; 2009 Apr; 37(7):2070-86. PubMed ID: 19223331
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sp1 mediates cell proliferation-dependent regulation of rat DNA topoisomerase IIalpha gene promoter.
    Yoon JH; Kim JK; Rha GB; Oh M; Park SH; Seong RH; Hong SH; Park SD
    Biochem J; 1999 Dec; 344 Pt 2(Pt 2):367-74. PubMed ID: 10567217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.